Results 131 to 140 of about 190,360 (263)

Pediatric care coordination and oral health outcomes among children with mental disorders in the United States. [PDF]

Prev Med Rep
Amedari MI, Heaton LJ, Dobbs T, Ivey K, Agbonlahor O, Walker B.   +5 more
europepmc   +1 more source

Social Determinants of Health Among Chinese Americans at Risk for Diabetes in a Mobile Diabetes Prevention Trial: Cross-Sectional Baseline Analysis. [PDF]

JMIR Diabetes
Jiang N, Liu J, Song H, Zhao Y, Li H, Yi SS, Beasley JM, Hu L.   +7 more
europepmc   +1 more source

How the HTAR will contribute to a value‐based decision‐making for medicinal products across the EU

British Journal of Clinical Pharmacology, EarlyView.
The European Union Health Technology Regulation 2021/2282 (HTAR) introduces joint assessment of health technologies (including medicinal products and medical devices) across EU Member States. It was signed into law in 2021 and came into full force in January 2025.
Roisin Adams, Michal Stanak
wiley   +1 more source

Rural-Urban Disparities in Epilepsy Outcomes in the United States. [PDF]

Neurology
Bader ER, Kemball-Cook WS, Benton JA, Killian NJ, Boro AD, Eskandar EN.   +5 more
europepmc   +1 more source

Efficacy, safety and cost‐effectiveness of CAR‐T therapy

British Journal of Clinical Pharmacology, EarlyView.
CAR T‐cells demonstrate high efficacy in blood cancers, including ALL, MM and DLBCL. Innovations target solid tumours despite challenges such as antigen escape. Combination therapies enhance the delivery and infiltration of CAR T cells. Toxicity, cost and resistance remain major barriers to clinical use.
Emina Karahmet Sher, Amina Džidić‐Krivić, Emma Pinjic, Nejra Selak, Kanita Omerbasic, Alexandar Chupin, Andrej Belancic, Almir Fajkic   +7 more
wiley   +1 more source

Geographic Analysis of Access to the National Diabetes Prevention Program in New York State. [PDF]

Prev Med Rep
Vrany EA, Chiuzan C, Oh EJ, Ephraim PL, Austin RA, Brissette IF, Millstein SL, Fitzpatrick SL.   +7 more
europepmc   +1 more source

Do drugs approved via expedited approval pathways have therapeutic advantages? A systematic review and meta‐analysis

British Journal of Clinical Pharmacology, EarlyView.
Regulators use expedited approval pathways to speed market approval and patient access to promising new drugs. However, there is uncertainty about whether these pathways are successful in approving drugs with significant therapeutic advantages. This systematic review aims to examine the safety, effectiveness and cost‐effectiveness of drugs approved via
Ashleigh Hooimeyer, Eliza J. McEwin, Zhicheng Wang, Joel Lexchin, Barbara Mintzes   +4 more
wiley   +1 more source

Oral Health Care in the United States. [PDF]

Dent J (Basel)
Duangthip D, Ammar S, Howard F, Chen X.
europepmc   +1 more source

Impact of secured prescription implementation on ambulatory pregabalin use in France: A regional assessment in the French Nouvelle‐Aquitaine

British Journal of Clinical Pharmacology, EarlyView.
Abstract Aim The French authorities mandated the use of secure prescriptions for pregabalin on May 2021. This study aimed to evaluate the impact of this measure on pregabalin use and misuse in Nouvelle‐Aquitaine, a southwestern French region with around six million inhabitants.
Maika Munech‐Herran, Véronique Moysan, Bruno Lescarret, Clément Mathieu, Antoine Pariente, Nicolas Rousselot   +5 more
wiley   +1 more source

The impact of Medicaid expansion on coverage among those lacking housing basics, 2010-2019. [PDF]

Health Aff Sch
Zhang C, Freund D, Kominski GF, Rasmussen PW.   +3 more
europepmc   +1 more source